This article needs additional citations for verification .(January 2021) |
Omani nationals have free access to the country's public healthcare, though expatriates typically seek medical care in private sector clinics and hospitals. Generally, the standard of care in the public sector is high for a middle-income country. Oman now has very low rate of once common communicable diseases such as measles and typhoid. Due to rapidly increasing incomes and changing lifestyles and diet, the levels of non-communicable diseases such as cardiovascular disease and diabetes are an increasing problem.
The hospitals in Oman generally provide a high quality of health care. Most of the largest and most advanced hospitals and health centres are located in Muscat, such as the Royal Hospital of Oman and the Sultan Qaboos University Hospital. [1]
Though the Omanis have a high life expectancy of 73.8 the nation's medical industry can not be compared to other more developed countries. Still the government is trying to develop this sector and encourage students to study medicine. Although a sizeable portion of the healthcare workforce is foreign born, due to an aggressive government policy of Omanization, this is beginning to change. The country now has an accredited medical university and many Omani doctors have obtained their medical training in countries such as Australia, Canada, the United Kingdom and the United States.
Integrating Health Technology Assessment (HTA) aims to improve healthcare resource allocation. [2] HTA is a multidisciplinary process that evaluates the benefits and value of health technologies to support decision-making and promote efficient resource allocation. [3] [4] A recent study developed a roadmap for HTA implementation, highlighting the need for training, sustainable funding, and a structured organizational framework [5]
The study outlined a set of recommendations to bridge the gap between the current and desired HTA status in Oman:
Oman should focus on developing comprehensive training programs in the short term, with plans to establish graduate programs in the long term. Short courses and workshops should be maintained to provide ongoing education for current professionals. Introducing undergraduate courses in health economics for medical and pharmacy students will help foster a foundational understanding of HTA.
Funding for HTA should primarily come from the Ministry of Health, with additional contributions from the private sector. This balanced funding model will ensure the sustainability of the HTA process and support comprehensive evaluations.
A national HTA unit will be established under the Ministry of Health to coordinate and oversee all HTA activities, ensuring consistency and efficiency in the evaluation process. Initially, this unit will focus on high-budget pharmaceuticals and later expand to include medical devices, surgical interventions, and prevention programs.
Expanding the scope of HTA is necessary to include various health technologies such as pharmaceuticals, medical devices, prevention programs, and surgical interventions. Revising existing policies using HTA will ensure they reflect current evidence and best practices. This expansion should be phased, prioritizing high-impact areas initially and gradually extending to other technologies over time.
Implementing decision criteria involves adopting explicit soft thresholds for cost-effectiveness and piloting the Multi-Criteria Decision Analysis (MCDA) framework. This will systematically evaluate multiple factors including cost-effectiveness, therapeutic value, and budget impact in the decision-making process. Ensure Quality and Transparency Ensuring quality and transparency requires developing methodological guidelines for HTA to standardize the appraisal process and improve the quality of assessments. Publishing HTA reports, critical appraisals, and recommendations will make the process more transparent and foster stakeholder trust. Setting clear timelines for HTA submissions and recommendations will ensure timely and predictable decision-making.
Utilizing local data is essential and this can be achieved by mandating the inclusion of local data in HTA to ensure relevance and accuracy in the Omani context. Developing robust databases such as patient registries and payer databases will provide high-quality, accessible data for HTA. Establishing partnerships with healthcare providers and insurers will enhance data sharing and access for HTA purposes.
Fostering international collaboration involves participating in and hosting HTA training programs and working with regional bodies like the Gulf Cooperation Council (GCC). This will help leverage global expertise and avoid duplicative efforts. Organizing and participating in international HTA courses and workshops will build local expertise and keep professionals updated on global HTA advancements.
A medical guideline is a document with the aim of guiding decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare. Such documents have been in use for thousands of years during the entire history of medicine. However, in contrast to previous approaches, which were often based on tradition or authority, modern medical guidelines are based on an examination of current evidence within the paradigm of evidence-based medicine. They usually include summarized consensus statements on best practice in healthcare. A healthcare provider is obliged to know the medical guidelines of their profession, and has to decide whether to follow the recommendations of a guideline for an individual treatment.
Evidence-based design (EBD) is the process of constructing a building or physical environment based on scientific research to achieve the best possible outcomes. Evidence-based design is especially important in evidence-based medicine, where research has shown that environment design can affect patient outcomes. It is also used in architecture, interior design, landscape architecture, facilities management, education, and urban planning. Evidence-based design is part of the larger movement towards evidence-based practices.
Clinical audit is a process that has been defined as a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criteria and the implementation of change
Health technology is defined by the World Health Organization as the "application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures, and systems developed to solve a health problem and improve quality of lives". This includes pharmaceuticals, devices, procedures, and organizational systems used in the healthcare industry, as well as computer-supported information systems. In the United States, these technologies involve standardized physical objects, as well as traditional and designed social means and methods to treat or care for patients.
Due to the near-universal desire for safe, effective, and high quality healthcare, there is a growing interest in international healthcare accreditation. Providing healthcare, especially of an adequate standard, is a complex and challenging process. Healthcare is a vital and pervasive issue; it influences all aspects of societies. It has medical, social, political, ethical, business, and financial ramifications. In any part of the world healthcare services can be provided either by the public sector or by the private sector, or by a combination of the two. Healthcare can be provided in hospitals or be accessed through practitioners working in the community, such as general medical practitioners and dental surgeons.
Healthcare in Finland consists of a highly decentralized three-level publicly funded healthcare system and a much smaller private sector. Although the Ministry of Social Affairs and Health has the highest decision-making authority, specific healthcare precincts are responsible for providing healthcare to their residents as of 2023.
Healthcare in Georgia is provided by a universal health care system under which the state funds medical treatment in a mainly privatized system of medical facilities. In 2013, the enactment of a universal health care program triggered universal coverage of government-sponsored medical care of the population and improving access to health care services. Responsibility for purchasing publicly financed health services lies with the Social Service Agency (SSA).
Health technology assessment (HTA) is a multidisciplinary process that uses systematic and explicit methods to evaluate the properties and effects of a health technology. Health technology is conceived as any intervention at any point in its lifecycle. The purpose of HTA is to inform "decision-making in order to promote an equitable, efficient, and high-quality health system". It has other definitions including "a method of evidence synthesis that considers evidence regarding clinical effectiveness, safety, cost-effectiveness and, when broadly applied, includes social, ethical, and legal aspects of the use of health technologies. The precise balance of these inputs depends on the purpose of each individual HTA. A major use of HTAs is in informing reimbursement and coverage decisions by insurers and national health systems, in which case HTAs should include benefit-harm assessment and economic evaluation." And "a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific method".
Patient participation is a trend that arose in answer to medical paternalism. Informed consent is a process where patients make decisions informed by the advice of medical professionals.
Decision aids are interventions or tools designed to facilitate shared decision making and patient participation in health care decisions.
Medical technology assessment (MTA) is the objective evaluation of a medical technology regarding its safety and performance, its (future) impact on clinical and non-clinical patient outcomes as well as its interactive effects on economical, organizational, social, juridical and ethical aspects of healthcare. Medical technologies are assessed both in absolute terms and in comparison to other (combinations of) medical technologies, procedures, treatments or ‘doing-nothing’.
European Network for Health Technology Assessment (EUnetHTA) is a network, established to create an effective and sustainable structure for health technology assessment (HTA) across Europe that could develop and implement practical tools to provide reliable, timely, transparent and transferable information to contribute to HTAs in Member States.
India has a multi-payer universal health care model that is paid for by a combination of public and government regulated private health insurances along with the element of almost entirely tax-funded public hospitals. The public hospital system is essentially free for all Indian residents except for small, often symbolic co-payments in some services. Economic Survey 2022-23 highlighted that the Central and State Governments’ budgeted expenditure on the health sector reached 2.1% of GDP in FY23 and 2.2% in FY22, against 1.6% in FY21. India ranks 78th and has one of the lowest healthcare spending as a percent of GDP. It also ranks 77th on the list of countries by total health expenditure per capita.
Health care quality is a level of value provided by any health care resource, as determined by some measurement. As with quality in other fields, it is an assessment of whether something is good enough and whether it is suitable for its purpose. The goal of health care is to provide medical resources of high quality to all who need them; that is, to ensure good quality of life, cure illnesses when possible, to extend life expectancy, and so on. Researchers use a variety of quality measures to attempt to determine health care quality, including counts of a therapy's reduction or lessening of diseases identified by medical diagnosis, a decrease in the number of risk factors which people have following preventive care, or a survey of health indicators in a population who are accessing certain kinds of care.
Healthcare in Belize is provided through both public and private healthcare systems. The Ministry of Health (MoH) is the government agency responsible for overseeing the entire health sector and is also the largest provider of public health services in Belize. The MoH offers affordable care to a majority of Belizeans with a strong focus on providing quality healthcare through a range of public programs and institutions.
The Egyptian healthcare system is pluralistic, comprising a variety of healthcare providers from the public as well as the private sector. The government ensures basic universal health coverage, although private services are also available for those with the ability to pay. Due to social and economic pressures, Egypt's healthcare system is subject to many challenges. However, several recent efforts have been directed towards enhancing the system.
Model for assessment of telemedicine (MAST) is a framework for assessment of the value of telemedicine.
The Health Intervention and Technology Assessment Program (HITAP) is a semi-autonomous research unit under Thailand’s Ministry of Public Health. It was established in 2007 as a non-profit organization in order to take responsibility for appraising a wide range of health technologies and programs, including pharmaceuticals, medical devices, interventions, individual and community health promotion, and disease prevention as well as social health policy to inform policy decisions in Thailand. HITAP assumes an advisory role to health governmental authorities by providing rigorous scientific evidence through professional assessment of health data in support of public decision-making. These assessments cover a range of topics including system design, selection of technologies for assessment, and the actual assessment of those selected and agreed upon by relevant government agencies. In this effort, HITAP publishes research and studies in the following areas: methodological development, databases and guidelines; knowledge transfer and exchange (KTE) and capacity development; technology assessments on drugs, medical devices, medical procedures, disease prevention and health promotion measures; benefit packages of care – mixing screening and treatments; and other public health policies, e.g. evaluation of Thailand’s government compulsory license policy.
Guidances for statistics in regulatory affairs refers to specific documents or guidelines that provide instructions, recommendations, and standards pertaining to the application of statistical methodologies and practices within the regulatory framework of industries such as pharmaceuticals and medical devices. These guidances serve as a reference for statisticians, researchers, and professionals involved in designing, conducting, analyzing, and reporting studies and trials in compliance with regulatory requirements. These documents embody the prevailing perspectives of regulatory agencies on specific subjects. It is worth noting that in the United States, the term "Guidances" is used, while in Europe, the term "Guidelines" is employed.
Hilal bin Ali bin Hilal Al-Sabti was born on October 27, 1972. On June 16, 2022, His Majesty Sultan Haitham Bin Tariq has issued a Royal Decree appointing Dr. Hilal bin Ali bin Hilal Al Sabti, as the new Minister of Health. He succeeded His Excellency Dr. Ahmed Al Saidi on this new role.